Virtual reality vs. relaxing videos: a new weapon against chemo side effects?
NCT ID NCT06863623
First seen Jul 29, 2026 · Last updated Sep 18, 2026 · Updated 2 times
Summary
This trial tests whether immersive virtual reality or relaxing nature videos can reduce symptom severity, distress, and improve quality of life in people with lung cancer who are starting chemotherapy. Participants will be randomly assigned to one of three groups: virtual reality sessions, relaxing videos, or standard care. The goal is to see if these calming, non-drug methods can help manage common chemotherapy side effects like nausea, fatigue, and emotional distress.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- immersive virtual reality and relaxing videos
- What this could lead to
- If effective, these non-drug approaches could offer a simple, drug-free way to reduce symptom severity and distress during chemotherapy.
- What could go wrong
- This is a relatively small, early-stage trial. The effects may be modest, and not all patients may tolerate or benefit from virtual reality or video interventions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
315 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * are over 18 years old, * diagnosed with lung cancer, * will receive chemotherapy for the first time, * will receive at least 2 cycles of chemotherapy treatment * agree to participate in the study * ECOG performance status of 2 or less Exclusion Criteria: * Having a cognitive and psychiatric disorder and diagnosis, * Having brain metastasis or chronic disease related to the head-brain region, * Having vision-hearing problems, * Having epilepsy, vertigo, chronic severe headache, dizziness problems, * Having a history of virtual reality, simulator or motion sickness, * Having/declaring that he/she has open area, underwater, specific animal phobia, * Do not agree to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chemotherapy effect are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
-
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye)
-
Hacettepe University Oncology Hospital
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
- Can an Anti-Fibrotic drug shield lungs from radiation after immunotherapy?
- Can a smartwatch predict which cancer patients return to hospital?
- Can teachers and a phone app ease teen depression?
- App aims to catch a hidden radiotherapy side effect
- Which nerve block wins for lung surgery pain?